Financials data is unavailable for this security.
View more
Year on year DNA Chip Research Inc grew revenues 49.74% from 327.54m to 490.46m while net income improved from a loss of 362.34m to a smaller loss of 248.29m.
Gross margin | 38.52% |
---|---|
Net profit margin | -15.41% |
Operating margin | -16.85% |
Return on assets | -14.12% |
---|---|
Return on equity | -18.91% |
Return on investment | -17.74% |
More ▼
Cash flow in JPYView more
In 2024, DNA Chip Research Inc increased its cash reserves by 41.05%, or 113.05m. Cash Flow from Financing totalled 269.05m or 54.86% of revenues. In addition the company used 140.23m for operations while cash used for investing totalled 15.78m.
Cash flow per share | -10.69 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 103.64 |
---|---|
Tangible book value per share | 85.58 |
More ▼
Balance sheet in JPYView more
Current ratio | 3.07 |
---|---|
Quick ratio | 2.78 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼